Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Nov;61(592):e684-91.
doi: 10.3399/bjgp11X606573.

Risk of prostate cancer associated with benign prostate disease: a primary care case-control study

Brian S Buckley  1 , Marie Carmela M Lapitan, Colin R Simpson, Aziz Sheikh
Affiliations
Comparative Study

Risk of prostate cancer associated with benign prostate disease: a primary care case-control study

Brian S Buckley et al. Br J Gen Pract. 2011 Nov.

Abstract

Background: Benign diseases of the prostate are common in the general male population, and prostate cancer is the most common cancer in men. Uncertainty as to the nature of the association between benign and malignant disease is a source of concern for patients and clinicians.

Aim: To determine the likelihood of men with benign prostate disease developing prostate cancer compared with men without disease.

Design: Incident matched case-control study.

Method: All incident cases of prostate cancer (n = 984) were identified in a nationally representative community-based population, and each was matched by age with two controls with no prostate cancer (n = 1968). Participants' records of the previous 5 years were searched for diagnoses of benign prostate disease. Analyses investigated an a priori hypothesis that clinicians may record disease as benign until proven to be malignant, causing misleading significant associations between benign and malignant diagnoses.

Results: There was a significant association between a diagnosis of prostate cancer and a benign diagnosis at any time in the previous 5 years: odds ratio (OR) 1.57 (95% confidence interval [CI] = 1.32 to 1.88). However, there was no significant association when benign diagnoses within 6 months and within 12 months of cancer diagnoses were excluded: OR 1.19 (95% CI = 0.97 to 1.46) and OR 1.00 (95% CI = 0.79 to 1.27) respectively.

Conclusion: Findings from this study suggest that unless prostate cancer is detected within 6 months, men diagnosed for the first time with benign disease are at no greater risk of prostate cancer than those with no recorded prostate disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Prostate cancer (new cases) 2001-2005 by 10-year age group: study cases versus Scottish national data cases (Information Services Division).
Figure 2
Figure 2
Steps in data analysis. Cases = men diagnosed with prostate cancer. Controls = men of same age with no cancer diagnosis (two controls per case) on date of case's diagnosis.
See this image and copyright information in PMC

Comment in

References

    1. Naslund MJ, Gilsenan AW, Midkiff KD, et al. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting. Int J Clin Pract. 2007;61(9):1437–1445. - PubMed
    1. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256–1261. - PubMed
    1. Jacobsen SJ, Girman CJ, Lieber MM. Natural history of benign prostatic hyperplasia. Urology. 2001;58(suppl 6a):5–16. - PubMed
    1. Bright E, Abrams P. Diseases of the prostate. Rev Clin Gerontol. 2010;20:10–19.
    1. Young JM, Muscatello DJ, Ward JE. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. BJU Int. 2000;85(9):1037–1048. - PubMed

Publication types